Product
CSs
1 clinical trial
1 indication
Indication
Juvenile Idiopathic ArthritisClinical trial
A Phase IV, Multicenter, Single-Arm, Open-Label Study to Assess the Efficacy and Safety of Tocilizumab in Chinese Patients With Systemic Juvenile Idiopathic ArthritisStatus: Completed, Estimated PCD: 2021-09-04